Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
주식 순위 #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
주가
$0.78611575
시가총액
$60.45M
변동 (1일)
0.00%
변동 (1년)
-12.06%
국가
NO
거래 Lytix Biopharma AS (LYTIX)

카테고리

Lytix Biopharma AS (LYTIX)의 주가 이력
최고 종가: $0.83 (2026-08-01 기준)

최저 종가: $1.84 (2021-06-01 기준)
Lytix Biopharma AS의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$546.40 37.47%
US
$1.05K 57.85%
NL
$118.70 -18.24%
AU
$140.43 435.58%
US
$770.19 9.84%
CH